SD

Shaitan Dan

Active Director Director DIN 10206290
DIN 10206290 First appointment Jun 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value •••• Premium profile

About Shaitan Dan

Data last updated:

Shaitan Dan is a Director at Biogenith Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Biogenith Pharmaceuticals Private Limited reported revenue of ₹12,886 (FY 2024).

DIN 10206290
Primary Designation Director
Industry Pharma
First Appointment 19 Jun 2023
Oldest Company Age 3 yrs
Largest company Biogenith Pharmaceuticals Private Limited · ₹12,886 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Jun 20232023₹12,886 (FY 2024)Active

Board colleagues of Shaitan Dan

NameDINCompanyDesignation
Tarun Singh Charan10206291Biogenith Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Biogenith Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Shaitan Dan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shaitan Dan

Shaitan Dan currently holds 1 directorship: Biogenith Pharmaceuticals Private Limited (Director, since 19 Jun 2023, revenue ₹12,886 (FY 2024)).

Shaitan Dan was first appointed on 19 Jun 2023 as Director at Biogenith Pharmaceuticals Private Limited.

The current boards of Shaitan Dan's companies include Tarun Singh Charan (Biogenith Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available